Nyxoah (NYXH) to Release Earnings on Tuesday

Nyxoah (NASDAQ:NYXHGet Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of ($0.48) per share for the quarter.

Nyxoah Trading Up 0.1 %

NASDAQ NYXH opened at $10.36 on Tuesday. The firm’s 50 day moving average price is $9.77 and its two-hundred day moving average price is $9.01. The stock has a market cap of $352.86 million, a price-to-earnings ratio of -5.54 and a beta of 1.41. Nyxoah has a twelve month low of $6.76 and a twelve month high of $20.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on NYXH. HC Wainwright reissued a “buy” rating and set a $17.00 target price on shares of Nyxoah in a research note on Friday, December 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $16.00 target price on shares of Nyxoah in a research note on Tuesday, November 5th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Nyxoah presently has an average rating of “Buy” and an average price target of $17.00.

View Our Latest Report on NYXH

Nyxoah Company Profile

(Get Free Report)

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

Recommended Stories

Earnings History for Nyxoah (NASDAQ:NYXH)

Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.